Literature DB >> 3132238

Danger of interaction between ciprofloxacin and theophylline.

J L Bem1, R D Mann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3132238      PMCID： PMC2545536          DOI： 10.1136/bmj.296.6629.1131

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  A clinically significant interaction between ciprofloxacin and theophylline.

Authors:  A H Thomson; G D Thomson; M Hepburn; B Whiting
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Quinolones and raised plasma concentrations of theophylline.

Authors:  F P Maesen; J P Teengs; C Baur; B I Davies
Journal:  Lancet       Date:  1984-09-01       Impact factor: 79.321

3.  The influence of quinolone derivatives on theophylline clearance.

Authors:  W J Wijnands; T B Vree; C L van Herwaarden
Journal:  Br J Clin Pharmacol       Date:  1986-12       Impact factor: 4.335
  3 in total
  8 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

Review 2.  Adverse reactions and interactions with theophylline.

Authors:  M H Skinner
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

3.  The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.

Authors:  K T Batty; T M Davis; K F Ilett; L J Dusci; S R Langton
Journal:  Br J Clin Pharmacol       Date:  1995-03       Impact factor: 4.335

4.  The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes.

Authors:  V Spaldin; S Madden; W F Pool; T F Woolf; B K Park
Journal:  Br J Clin Pharmacol       Date:  1994-07       Impact factor: 4.335

5.  Inhibitory potency of quinolone antibacterial agents against cytochrome P450IA2 activity in vivo and in vitro.

Authors:  U Fuhr; E M Anders; G Mahr; F Sörgel; A H Staib
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

6.  4-quinolones inhibit biotransformation of caffeine.

Authors:  S Harder; A H Staib; C Beer; A Papenburg; W Stille; P M Shah
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 7.  Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.

Authors:  F Pea; M Furlanut
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 5.577

8.  Incidence rate and pattern of clinically relevant potential drug-drug interactions in a large outpatient population of a developing country.

Authors:  Ehsan Nabovati; Hasan Vakili-Arki; Zhila Taherzadeh; Mohammad Reza Saberi; Ameen Abu-Hanna; Saeid Eslami
Journal:  Res Pharm Sci       Date:  2016 May-Jun
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.